Trial Profile
Early Serum Infliximab Levels in Severe Ulcerative Colitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Infliximab (Primary)
- Indications Ulcerative colitis
- Focus Therapeutic Use
- Acronyms EaSiFx
- 26 May 2015 Status changed from recruiting to completed according to ClinicalTrials.gov record.
- 03 Jul 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 06 Nov 2013 New trial record